283 related articles for article (PubMed ID: 37868979)
1.
Ding YD; Shu LZ; He RS; Chen KY; Deng YJ; Zhou ZB; Xiong Y; Deng H
Front Immunol; 2023; 14():1278011. PubMed ID: 37868979
[TBL] [Abstract][Full Text] [Related]
2. Clinical Experience and Recent Advances in the Development of
Oladejo M; Paterson Y; Wood LM
Front Immunol; 2021; 12():642316. PubMed ID: 33936058
[TBL] [Abstract][Full Text] [Related]
3. Attenuated Listeria monocytogenes: a powerful and versatile vector for the future of tumor immunotherapy.
Wood LM; Paterson Y
Front Cell Infect Microbiol; 2014; 4():51. PubMed ID: 24860789
[TBL] [Abstract][Full Text] [Related]
4. Listeria monocytogenes as a vector for tumor-associated antigens for cancer immunotherapy.
Singh R; Paterson Y
Expert Rev Vaccines; 2006 Aug; 5(4):541-52. PubMed ID: 16989634
[TBL] [Abstract][Full Text] [Related]
5. Agonist anti-GITR antibody significantly enhances the therapeutic efficacy of Listeria monocytogenes-based immunotherapy.
Shrimali R; Ahmad S; Berrong Z; Okoev G; Matevosyan A; Razavi GSE; Petit R; Gupta S; Mkrtichyan M; Khleif SN
J Immunother Cancer; 2017 Aug; 5(1):64. PubMed ID: 28807056
[TBL] [Abstract][Full Text] [Related]
6. Direct incorporation of the NKT-cell activator α-galactosylceramide into a recombinant Listeria monocytogenes improves breast cancer vaccine efficacy.
Singh M; Quispe-Tintaya W; Chandra D; Jahangir A; Venkataswamy MM; Ng TW; Sharma-Kharkwal S; Carreño LJ; Porcelli SA; Gravekamp C
Br J Cancer; 2014 Nov; 111(10):1945-54. PubMed ID: 25314062
[TBL] [Abstract][Full Text] [Related]
7. Cancer immunotherapy using recombinant Listeria monocytogenes: transition from bench to clinic.
Singh R; Wallecha A
Hum Vaccin; 2011 May; 7(5):497-505. PubMed ID: 21422819
[TBL] [Abstract][Full Text] [Related]
8. Prospects and progress of Listeria-based cancer vaccines.
Bolhassani A; Naderi N; Soleymani S
Expert Opin Biol Ther; 2017 Nov; 17(11):1389-1400. PubMed ID: 28823183
[TBL] [Abstract][Full Text] [Related]
9. Prophylactic and therapeutic efficacy of an attenuated Listeria monocytogenes-based vaccine delivering HPV16 E7 in a mouse model.
Jia Y; Yin Y; Duan F; Fu H; Hu M; Gao Y; Pan Z; Jiao X
Int J Mol Med; 2012 Dec; 30(6):1335-42. PubMed ID: 23027427
[TBL] [Abstract][Full Text] [Related]
10. Listeria monocytogenes and its products as agents for cancer immunotherapy.
Guirnalda P; Wood L; Paterson Y
Adv Immunol; 2012; 113():81-118. PubMed ID: 22244580
[TBL] [Abstract][Full Text] [Related]
11. Impact of preexisting vector-specific immunity on vaccine potency: characterization of listeria monocytogenes-specific humoral and cellular immunity in humans and modeling studies using recombinant vaccines in mice.
Leong ML; Hampl J; Liu W; Mathur S; Bahjat KS; Luckett W; Dubensky TW; Brockstedt DG
Infect Immun; 2009 Sep; 77(9):3958-68. PubMed ID: 19528221
[TBL] [Abstract][Full Text] [Related]
12. Listeria monocytogenes activated dendritic cell based vaccine for prevention of experimental tumor in mice.
Khamisabadi M; Arab S; Motamedi M; Khansari N; Moazzeni SM; Gheflati Z; Hadjati J
Iran J Immunol; 2008 Mar; 5(1):36-44. PubMed ID: 18319523
[TBL] [Abstract][Full Text] [Related]
13. Harnessing Listeria monocytogenes to target tumors.
Gravekamp C; Paterson Y
Cancer Biol Ther; 2010 Feb; 9(4):257-65. PubMed ID: 20139702
[TBL] [Abstract][Full Text] [Related]
14. Live-attenuated Listeria-based immunotherapy.
Rothman J; Paterson Y
Expert Rev Vaccines; 2013 May; 12(5):493-504. PubMed ID: 23659298
[TBL] [Abstract][Full Text] [Related]
15.
Morrow ZT; Powers ZM; Sauer JD
Curr Clin Microbiol Rep; 2019 Dec; 6(4):213-224. PubMed ID: 33072493
[TBL] [Abstract][Full Text] [Related]
16. Recombinant
Deng W; Lira V; Hudson TE; Lemmens EE; Hanson WG; Flores R; Barajas G; Katibah GE; Desbien AL; Lauer P; Leong ML; Portnoy DA; Dubensky TW
Proc Natl Acad Sci U S A; 2018 Aug; 115(32):8179-8184. PubMed ID: 30038013
[TBL] [Abstract][Full Text] [Related]
17. Listeria-based immunotherapy directed against CD105 exerts anti-angiogenic and anti-tumor efficacy in renal cell carcinoma.
Oladejo M; Nguyen HM; Silwal A; Reese B; Paulishak W; Markiewski MM; Wood LM
Front Immunol; 2022; 13():1038807. PubMed ID: 36439126
[TBL] [Abstract][Full Text] [Related]
18. Tumor-associated antigen expressing Listeria monocytogenes induces effective primary and memory T-cell responses against hepatic colorectal cancer metastases.
Olino K; Wada S; Edil BH; Pan X; Meckel K; Weber W; Slansky J; Tamada K; Lauer P; Brockstedt D; Pardoll D; Schulick R; Yoshimura K
Ann Surg Oncol; 2012 Jul; 19 Suppl 3(Suppl 3):S597-607. PubMed ID: 21979110
[TBL] [Abstract][Full Text] [Related]
19. Listeria-based anti-infective vaccine strategies.
Liu D
Recent Pat Antiinfect Drug Discov; 2006 Nov; 1(3):281-90. PubMed ID: 18221153
[TBL] [Abstract][Full Text] [Related]
20. Regression of HPV-positive tumors treated with a new Listeria monocytogenes vaccine.
Sewell DA; Douven D; Pan ZK; Rodriguez A; Paterson Y
Arch Otolaryngol Head Neck Surg; 2004 Jan; 130(1):92-7. PubMed ID: 14732776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
